| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.52 | 0.0007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |